CORIN PESCI: Open Payments
NPI 1013013762 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 48 payments from 12 companies in 2025. Trend: 2023 $717 · 2024 $2,739 · 2025 $1,007
Food & beverage: $907Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $266 |
| UCB, Inc. | 6 | $162 |
| ABBVIE INC. | 6 | $129 |
| Amgen Inc. | 5 | $115 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Janssen Biotech, Inc. | 3 | $49 |
| Organogenesis Inc. | 1 | $39 |
| Lilly USA, LLC | 2 | $38 |
Products named: Sotyktu, Bimzelx, OTEZLA, SKYRIZI, Zoryve, DUPIXENT, TREMFYA, RINVOQ.
Industry payments across NC — which companies pay providers there.
